Deconstructing sub-clinical psychosis into latent-state and trait variables over a 30-year time span

Schizophrenia Research

Volumn 150, Issue 1, 2013, Pages 197-204

  Rössler, Wulf ^a,b   Hengartner, Michael P ^a   Ajdacic Gross, Vladeta ^a   Haker, Helene ^b   Angst, Jules ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cannabis; Epidemiology; Latent state trait model; Schizotypal personality; Schizotypy; Sub clinical psychosis; Substance use

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COMMUNITY MENTAL HEALTH; COMMUNITY SAMPLE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ABUSE; EMPLOYMENT STATUS; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SELF ESTEEM; SWITZERLAND; SYMPTOM CHECKLIST 90; SYMPTOMATOLOGY;

CANNABIS; EPIDEMIOLOGY; LATENT STATE-TRAIT MODEL; SCHIZOTYPAL PERSONALITY; SCHIZOTYPY; SUB-CLINICAL PSYCHOSIS; SUBSTANCE USE;

CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; HUMANS; MALE; PERSONALITY; PSYCHOTIC DISORDERS; QUESTIONNAIRES; REGRESSION ANALYSIS; SWITZERLAND; TIME FACTORS; YOUNG ADULT;

EID: 84884136446     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.07.042     Document Type: Article

References (46)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR 2000, American Psychiatric Association, Washington, DC.
2. Angst J., Dobler-Mikola A., Binder J. The Zurich Study-a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. Problem, methodology. Eur. Arch. Psychiatry Neurol. Sci. 1984, 234(1):13-20.
3. Angst J., Gamma A., Neuenschwander M., Ajdacic-Gross V., Eich D., Rössler W., Merikangas K.R. Prevalence of mental disorders in the Zurich Cohort Study: a twenty year prospective study. Epidemiol. Psichiatr. Soc. 2005, 14(2):68-76.
4. Asai T., Sugimori E., Bando N., Tanno Y. The hierarchic structure in schizotypy and the five-factor model of personality. Psychiatry Res. 2011, 185(1-2):78-83.
5. Barkus E., Murray R.M. Substance use in adolescence and psychosis: clarifying the relationship. Annu. Rev. Clin. Psychol. 2010, 6:365-389.
6. Breetvelt E.J., Boks M.P., Numans M.E., Selten J.P., Sommer I.E., Grobbee D.E., Kahn R.S., Geerlings M.I. Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population. Schizophr. Res. 2010, 120(1-3):184-190.
7. Derogatis L.R. Symptom Checklist 90, R-Version Manual I: Scoring, Administration, and Procedures for the SCL-90 1977, Johns Hopkins Press, Baltimore, MD.
8. Dinn W.M., Harris C.L., Aycicegi A., Greene P., Andover M.S. Positive and negative schizotypy in a student sample: neurocognitive and clinical correlates. Schizophr. Res. 2002, 56(1-2):171-185.
9. Dunn G., Pickles A., Tansella M., Vazquez-Barquero J.L. Two-phase epidemiological surveys in psychiatric research. Br. J. Psychiatry 1999, 174:95-100.
10. Eich D., Ajdacic-Gross V., Condrau M., Huber H., Gamma A., Angst J., Rössler W. The Zurich Study: participation patterns and Symptom Checklist 90-R scores in six interviews, 1979-99. Acta Psychiatr. Scand. Suppl. 2003, 108(s418):11-14.
11. Eid M., Schneider C., Schwenkmezger P. Do you feel better or worse? The validity of perceived deviations of mood states from mood traits. Eur. J. Pers. 1999, 13:283-306.
12. Fahrenberg J., Hampel R., Selg H. Das Freiburger Persönlichkeitsinventar FPI. Revidierte Fassung FPI-R und teilweise geänderte Fassung FPI-A1, 4. revidierte Auflage 1984, Hogrefe, Göttingen.
13. Geiser C. Datenanalyse mit Mplus: Eine anwendungsorientierte Einführung 2011, VS Verlag, Wiesbaden. 2. Auflage.
14. Hengartner M.P., Müller M., Rodgers S., Rössler W., Ajdacic-Gross V. Interpersonal functioning deficits in association with DSM-IV personality disorder dimensions. Soc. Psychiatry Psychiatr. Epidemiol 2013, 10.1007/s00127-013-0707-x.
15. Hengartner M.P., Müller M., Rodgers S., Rössler W., Ajdacic-Gross V. Occupational functioning and work impairment in association with personality disorder trait-scores. Soc. Psychiatry Psychiatr. Epidemiol 2013, 10.1007/s00127-013-0739-2.
16. Hobfoll S.E., Walfisch S. Coping with a threat to life: a longitudinal study of self-concept, social support, and psychological distress. Am. J. Community Psychol. 1984, 12(1):87-100.
17. Kendler K.S., Gallagher T.J., Abelson J.M., Kessler R.C. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch. Gen. Psychiatry 1996, 53(11):1022-1031.
18. Kline R.B. Principles and Practice of Structural Equation Modeling 2005, Guilford Press, New York. second ed.
19. Livesley W.J., Jang K.L. The behavioral genetics of personality disorder. Annu. Rev. Clin. Psychol. 2008, 4:247-274.
20. McCrae R.R., Löckenhoff C.E., Costa P.T. A step toward DSM-V: cataloguing personality-related problems in living. Eur. J. Pers. 2005, 19:269-286.
21. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
22. Muthén L.K., Muthén B.O. Mplus User's Guide 1998-2012, Muthén & Muthén, Los Angeles, CA. Seventh edition.
23. Nuevo R., Chatterji S., Verdes E., Naidoo N., Arango C., Ayuso-Mateos J.L. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr. Bull. 2012, 38(3):475-485.
24. Olsen L.R., Mortensen E.L., Bech P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr. Scand. 2004, 110(3):225-229.
25. Pearlin L.I., Schooler C. The structure of coping. J. Health. Soc. Behav. 1978, 19(1):2-21.
26. Perala J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsa E., Pirkola S., Partonen T., Tuulio-Henriksson A., Hintikka J., Kieseppa T., Harkanen T., Koskinen S., Lonnqvist J. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 2007, 64(1):19-28.
27. Raine A. Schizotypal personality: neurodevelopmental and psychosocial trajectories. Annu. Rev. Clin. Psychol. 2006, 2:291-326.
28. Raine A., Benishay D. The SPQ-B: a brief screening instrument for schizotypal personality disorder. J. Pers. Disord. 1995, 9:346-355.
29. Ross S.R., Lutz C.J., Bailley S.E. Positive and negative symptoms of schizotypy and the Five-factor model: a domain and facet level analysis. J. Pers. Assess. 2002, 79(1):53-72.
30. Rössler W., Salize H.J., van Os J., Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur. Neuropsychopharmacol. 2005, 15(4):399-409.
31. Rössler W., Riecher-Rössler A., Angst J., Murray R., Gamma A., Eich D., van Os J., Gross V.A. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr. Res. 2007, 92(1-3):1-14.
32. Rössler W., Hengartner M.P., Ajdacic-Gross V., Haker H., Gamma A., Angst J. Sub-clinical psychosis symptoms in young adults are risk factors for subsequent common mental disorders. Schizophr. Res. 2011, 131(1-3):18-23.
33. Rössler W., Vetter S., Mueller M., Gallo W.T., Haker H., Kawohl W., Lupi G., Ajdacic-Gross V. Risk factors at the low end of the psychosis continuum: much the same as at the upper end?. Psychiatry Res. 2011, 189(1):77-81.
34. Rössler W., Hengartner M.P., Ajdacic-Gross V., Haker H., Angst J. Sex differences in sub-clinical psychosis-results from a community study over 30years. Schizophr. Res. 2012, 139(1-3):176-182.
35. Rössler W., Hengartner M.P., Angst J., Ajdacic-Gross V. Linking substance use with symptoms of sub-clinical psychosis in a community cohort over 30years. Addiction 2012, 107(6):1174-1184.
36. Rössler W., Hengartner M.P., Ajdacic-Gross V., Haker H., Gamma A., Angst J. Lifetime and 12-month prevalence rates of sub-clinical psychosis symptoms in a community cohort of 50-year-old individuals. Eur. Psychiatry 2013, 28(5):302-307.
37. Schafer J.L., Graham J.W. Missing data: our view of the state of the art. Psychol. Methods 2002, 7(2):147-177.
38. Schmitz N., Hartkamp N., Kiuse J., Franke G.H., Reister G., Tress W. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Qual. Life. Res. 2000, 9(2):185-193.
39. Schreiber J.B., Stage F.K., King J., Nora A., Barlow E.A. Reporting structural equation modeling and confirmatory factor analysis results: a review. J. Educ. Res. 2006, 99(6):323-337.
40. Scott J., Chant D., Andrews G., McGrath J. Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychol. Med. 2006, 36(2):231-238.
41. Sörbom D. Detection of correlated errors in longitudinal data. Brit. J. Math. Stat. Psy. 1975, 28:138-151.
42. Steiger J.H. Understanding the limitations of global fit assessment in structural equation modeling. Pers. Individ. Dif. 2007, 42(5):893-898.
43. Steyer R., Schmitt M., Eid M. Latent state-trait theory and research in personality and individual differences. Eur. J. Pers. 1999, 13:389-408.
44. van Os J., Hanssen M., Bijl R.V., Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population?. Schizophr. Res. 2000, 45(1-2):11-20.
45. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009, 39(2):179-195.
46. Wiles N.J., Zammit S., Bebbington P., Singleton N., Meltzer H., Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br. J. Psychiatry 2006, 188:519-526.